Beam Therapeutics INC. (BEAM) SEC Filings — 2024
24 SEC filings for Beam Therapeutics INC. (BEAM) in 2024.
Filings
- Beam Therapeutics Files 8-K — 8-K · Dec 9, 2024
- Beam Therapeutics Announces Board and Executive Changes — 8-K · Dec 6, 2024
- Beam Therapeutics Appoints New Director, Discloses Officer Compensation — 8-K · Dec 4, 2024
- Beam Therapeutics INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Beam Therapeutics INC. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Beam Therapeutics INC. SC 13G/A Filing — SC 13G/A · Nov 7, 2024
- Beam Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 5, 2024
- Beam Therapeutics INC. SC 13G/A Filing — SC 13G/A · Oct 21, 2024
- Beam Therapeutics INC. SC 13G/A Filing — SC 13G/A · Oct 17, 2024
- Beam Therapeutics Q2 2024: Assets at $2.1B, Retained Earnings Negative — 10-Q · Aug 6, 2024
- Beam Therapeutics Adds Harvard Professor to Board — 8-K · Jul 15, 2024
- Beam Therapeutics Files 8-K on Shareholder Votes — 8-K · Jun 10, 2024
- Beam Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Beam Therapeutics Inc. files Definitive Proxy Statement for 2024 Annual Meeting — DEF 14A · Apr 19, 2024
- Beam Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
- Beam Therapeutics INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Beam Therapeutics INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Farallon Capital Partners Amends Beam Therapeutics Stake — SC 13G/A · Feb 12, 2024
- FMR LLC & Abigail Johnson Maintain 10.985% Stake in Beam Therapeutics — SC 13G/A · Feb 9, 2024
- Temasek Holdings Updates Passive Stake in Beam Therapeutics — SC 13G/A · Feb 6, 2024
- ARK Investment Management Boosts Stake in Beam Therapeutics — SC 13G/A · Jan 29, 2024
- BlackRock Amends Beam Therapeutics Stake, Signals Continued Confidence — SC 13G/A · Jan 25, 2024
- State Street Discloses Passive Stake in Beam Therapeutics — SC 13G · Jan 24, 2024
- Beam Therapeutics Files 8-K on Operations, Financial Condition — 8-K · Jan 8, 2024